Bill
Bill > A6184
summary
Introduced
12/08/2025
12/08/2025
In Committee
12/08/2025
12/08/2025
Crossed Over
Passed
Dead
01/12/2026
01/12/2026
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill establishes certain data reporting requirements for hospitals, so that the Division of Consumer Affairs (division) in the Department of Law and Public Safety can study, and annually report on, emerging trends in prescription drug pricing in hospitals. Current law requires pharmacy benefits managers, wholesale drug distributors, insurance issuers, and manufacturers to register with the division and report certain data to the division concerning prescription drug transactions. This bill extends similar reporting requirements to hospitals and includes hospitals as reporting entities subject to certain requirements under P.L.2023, c.106. Under this bill, hospitals will, to the extent allowed by law, report to the division the following minimum data, and other data that may be specified by the division. The division will annually notify hospitals for which specific drugs or drug groups for which reporting is required and a hospital shall have 60 days following such notification to report to the division the following: (1) minimum and maximum price paid for each indicated drug and drug group in the last calendar year, related to prescriptions under an insurance policy issued in the State; (2) volume in pricing units of each indicated drug and drug group that the hospital dispensed or administered in the last calendar year, for business in the State, in total and for each payer type as relevant; (3) total rebates, discounts, and price concessions received for each drug and drug group as indicated by the division in the last calendar year, for business in the State, in total and for each payer type as relevant; and (4) total net income received in the last calendar year for each drug and drug group as indicated by the division, for business in the State, in total and for each payer type as relevant. Disclosure of all information reported under this bill will be subject to protections under P.L.2023, c.106.
AI Summary
This bill establishes new prescription drug data reporting requirements for hospitals in New Jersey, expanding upon existing reporting requirements for other entities in the pharmaceutical supply chain. Hospitals will now be required to report detailed information to the Division of Consumer Affairs about specific drugs or drug groups, including the minimum and maximum prices paid, volume of drugs dispensed or administered, total rebates and discounts received, and total net income for each drug or drug group. The division will annually notify hospitals which specific drugs or drug groups need to be reported, and hospitals will have 60 days to submit the required data. The bill amends existing law to include hospitals as "reporting entities" and adds hospitals to the Drug Affordability Council's membership restrictions. Hospitals must certify their reported data as accurate under penalty of perjury, and failure to comply can result in significant civil penalties ranging from $10,000 to $100,000 per day. The collected data will be used to study emerging trends in prescription drug pricing, with the goal of making prescription drugs more affordable and accessible for New Jersey residents. All reported information will be kept confidential, with strict protections against unauthorized disclosure.
Committee Categories
Business and Industry
Sponsors (1)
Last Action
Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 12/08/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A6184 |
| BillText | https://pub.njleg.gov/Bills/2024/A6500/6184_I1.HTM |
Loading...